Australia launches new portal to distribute information on medicines shortages

27 May 2014
fionanash-big

An online portal which reports on medicines shortages in Australia was launched yesterday by the Assistant Minister for Health, Fiona Nash (pictured).

Trade body Medicines Australia welcomed the Medicines Shortages Information Initiative, which supports an ongoing exchange of information between industry and regulators. It worked with the Therapeutic Goods Administration (TGA) and the Generic Medicines Industry Association (GMiA) to provide the resource aimed at healthcare professionals and the community.

Chief executive Brendan Shaw said: “We know there are multiple factors that can contribute to unanticipated shortages in medicines supply, including things like manufacturing problems, logistical failures, unexpected or unpredictable outbreaks of disease with fluctuating local demand, or end user stockpiling practices. This information initiative will provide the tools needed to communicate effectively to the regulator and companies ahead of time, reducing the possibility of patients not being able to access their prescribed medicine due to a supply shortage, and minimising the impact on patients.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical